Jacques Fantini Selected Research

adamantyl-globotriaosyl ceramide

2/2006

A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacques Fantini Research Topics

Disease

12	Infections 06/2022 - 06/2002
7	COVID-19 06/2022 - 05/2020
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2010
7	Parkinson Disease (Parkinson's Disease) 01/2022 - 03/2010
7	Alzheimer Disease (Alzheimer's Disease) 07/2014 - 12/2002
3	Virus Diseases (Viral Diseases) 11/2021 - 12/2002
3	Neuroblastoma 10/2017 - 03/2016
2	Neoplasms (Cancer) 01/2022 - 01/2018
2	Diarrhea 04/2008 - 09/2002
2	Inflammation (Inflammations) 04/2008 - 06/2002
2	HIV Infections (HIV Infection) 01/2007 - 02/2006
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2002 - 03/2002
1	Cholera 01/2022
1	Disease Progression 01/2022
1	Proteostasis Deficiencies 01/2022
1	Amyloid Plaque 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Ulcerative Colitis 09/2010
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2010
1	Channelopathies 03/2010
1	Colonic Neoplasms (Colon Cancer) 06/2009
1	Vomiting 04/2008
1	Sepsis (Septicemia) 04/2008
1	Malnutrition (Nutritional Deficiencies) 04/2008
1	Septic Shock (Toxic Shock Syndrome) 10/2007
1	Foodborne Diseases 10/2007
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2003
1	HIV Enteropathy 01/2003
1	Weight Loss (Weight Reduction) 09/2002
1	Wounds and Injuries (Trauma) 06/2002
1	Hemorrhage 06/2002
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 03/2002

Drug/Important Bio-Agent (IBA)

11	Peptides (Polypeptides)IBA 01/2022 - 03/2002
10	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2007
9	GangliosidesIBA 01/2022 - 06/2009
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
6	LipidsIBA 01/2022 - 03/2002
6	SynucleinsIBA 01/2022 - 05/2011
6	CholesterolIBA 01/2019 - 09/2010
6	Amyloidogenic ProteinsIBA 07/2014 - 03/2010
4	AntibodiesIBA 06/2022 - 06/2009
4	CeramidesIBA 01/2018 - 02/2006
3	Neutralizing AntibodiesIBA 06/2022 - 01/2003
3	VaccinesIBA 11/2021 - 01/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2020 - 05/2020
3	anandamide (arachidonylethanolamide)IBA 01/2018 - 01/2017
3	Pharmaceutical PreparationsIBA 07/2014 - 11/2003
3	GlycolipidsIBA 01/2014 - 02/2006
3	MycotoxinsIBA 09/2010 - 09/2002
3	Amyloid beta-PeptidesIBA 02/2010 - 03/2002
3	GlycosphingolipidsIBA 02/2006 - 06/2002
2	Prion ProteinsIBA 01/2022 - 12/2002
2	SARS-CoV-2 spike proteinIBA 01/2022 - 11/2021
2	Azithromycin (Zithromax)FDA LinkGeneric 08/2020 - 08/2020
2	hydroxide ionIBA 08/2020 - 08/2020
2	Bexarotene (LGD1069)FDA Link 07/2014 - 03/2014
2	alpha-SynucleinIBA 01/2013 - 03/2010
2	Membrane LipidsIBA 01/2013 - 02/2010
2	SphingolipidsIBA 09/2010 - 03/2002
2	deoxynivalenolIBA 04/2008 - 09/2002
2	PatulinIBA 04/2008 - 06/2002
2	Indicators and Reagents (Reagents)IBA 04/2008 - 12/2002
1	Antiviral Agents (Antivirals)IBA 06/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2022
1	Synaptotagmins (Synaptotagmin)IBA 01/2022
1	Blocking AntibodiesIBA 11/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Chloroquine (Aralen)FDA LinkGeneric 05/2020
1	Coloring Agents (Dyes)IBA 03/2016
1	CalciumIBA 03/2016
1	EstersIBA 08/2011
1	DisaccharidesIBA 08/2011
1	Tyrosine (L-Tyrosine)FDA Link 05/2011
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2010
1	Ion Channels (Ion Channel)IBA 03/2010
1	Interleukin-8 (Interleukin 8)IBA 04/2008
1	ochratoxin AIBA 04/2008
1	Enterotoxins (Enterotoxin)IBA 10/2007
1	SuperantigensIBA 10/2007
1	PrionsIBA 01/2007
1	ChemokinesIBA 02/2006
1	adamantyl-globotriaosyl ceramideIBA 02/2006
1	Interleukin-2 (IL2)IBA 02/2006
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2003
1	Peptide Hydrolases (Proteases)FDA Link 11/2003
1	SodiumIBA 01/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2003
1	Glucose (Dextrose)FDA LinkGeneric 01/2003
1	Galactosylceramides (Galactocerebrosides)IBA 06/2002
1	DisulfidesIBA 03/2002

Therapy/Procedure

6	Therapeutics 01/2022 - 11/2003
1	Investigational Therapies (Experimental Therapy) 09/2010